(19)
(11) EP 3 571 227 A1

(12)

(43) Date of publication:
27.11.2019 Bulletin 2019/48

(21) Application number: 18711394.9

(22) Date of filing: 19.01.2018
(51) International Patent Classification (IPC): 
C07K 16/22(2006.01)
A61P 35/00(2006.01)
 C07K 16/28(2006.01)
(86) International application number:
PCT/IB2018/000088
(87) International publication number:
WO 2018/134681 (26.07.2018 Gazette 2018/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD TN

(30) Priority: 20.01.2017 US 201762448800 P
20.01.2017 EP 17305061

(71) Applicant: Sanofi
75008 Paris (FR)

(72) Inventors:
  • SHAPIRO, Gary
    Arlington, MA 02474 (US)
  • BROWER, Kevin
    Bridgewater, NJ 08807 (US)
  • FINN, Patrick
    Franklin, MA 02038 (US)
  • GREGORY, Richard, C.
    Bridgewater, NJ 08807 (US)
  • KODURI, Rao
    Bridgewater, NJ 08807 (US)
  • LIU, Feng
    San Diego, CA 92130 (US)
  • MALKOVA, Natalia
    Bridgewater, NJ 08807 (US)
  • MANKOO, Parminder
    Foster City, CA 94404 (US)
  • POLLARD, Jack, R.
    Bridgewater, NJ 08807 (US)
  • QIU, Huawei
    Bridgewater, NJ 08807 (US)
  • THEILHABER, Joachim
    Bridgewater, NJ 08807 (US)
  • WINTER, Christopher
    Swampscott, MA 01907 (US)
  • YU, Marcella
    Fremont, CA 94555 (US)

(74) Representative: Rai, Monika et al
Mathys & Squire LLP The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) ANTI-TGF-BETA ANTIBODIES AND THEIR USE